1. Home
  2. WMS vs PTGX Comparison

WMS vs PTGX Comparison

Compare WMS & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Advanced Drainage Systems Inc.

WMS

Advanced Drainage Systems Inc.

HOLD

Current Price

$141.91

Market Cap

10.3B

ML Signal

HOLD

Logo Protagonist Therapeutics Inc.

PTGX

Protagonist Therapeutics Inc.

HOLD

Current Price

$136.23

Market Cap

8.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WMS
PTGX
Founded
1966
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Containers/Packaging
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.3B
8.5B
IPO Year
2014
2016

Fundamental Metrics

Financial Performance
Metric
WMS
PTGX
Price
$141.91
$136.23
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
13
Target Price
$180.63
$108.23
AVG Volume (30 Days)
617.8K
691.9K
Earning Date
05-21-2026
05-07-2026
Dividend Yield
0.49%
N/A
EPS Growth
N/A
N/A
EPS
5.44
0.05
Revenue
$3,050,376,000.00
N/A
Revenue This Year
$5.23
$874.25
Revenue Next Year
$12.79
N/A
P/E Ratio
$25.82
$2,708.60
Revenue Growth
5.03
N/A
52 Week Low
$110.85
$50.49
52 Week High
$179.32
$143.29

Technical Indicators

Market Signals
Indicator
WMS
PTGX
Relative Strength Index (RSI) 44.22 59.49
Support Level $130.87 $125.32
Resistance Level $144.56 $141.10
Average True Range (ATR) 4.16 6.74
MACD -1.50 -0.80
Stochastic Oscillator 16.16 58.87

Price Performance

Historical Comparison
WMS
PTGX

About WMS Advanced Drainage Systems Inc.

Advanced Drainage Systems Inc designs, manufactures and markets water management solutions in the stormwater and onsite wastewater industries, providing superior drainage solutions for use in the construction and agriculture markets. The company's products are used across a broad range of end markets and applications, including non-residential, residential, infrastructure and agriculture applications. It has two reportable segments: Stormwater and Wastewater. It derives the majority of revenue from the Stormwater segment, which manufactures and markets thermoplastic corrugated pipe and complementary products, including single wall pipe, N-12 HDPE pipe, polypropylene pipe, StormTech, Nyloplast, Inserta Tee, water quality filters and structures, and NDS channel drains, and access boxes.

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.

Share on Social Networks: